General Information of the Protein
Protein ID
PT01250
Protein Name
A disintegrin and metalloproteinase with thrombospondin motifs 5
Secondarily
Protein Name
A disintegrin and metalloproteinase with thrombospondin motifs 11
ADMP-2
Aggrecanase-2
Gene Name
ADAMTS5
Secondarily
Gene Name
ADAMTS11
ADMP2
Sequence
MLLGWASLLLCAFRLPLAAVGPAATPAQDKAGQPPTAAAAAQPRRRQGEEVQERAEPPGHPHPLAQRRRSKGLVQNIDQLYSGGGKVGYLVYAGGRRFLLDLERDGSVGIAGFVPAGGGTSAPWRHRSHCFYRGTVDGSPRSLAVFDLCGGLDGFFAVKHARYTLKPLLRGPWAEEEKGRVYGDGSARILHVYTREGFSFEALPPRASCETPASTPEAHEHAPAHSNPSGRAALASQLLDQSALSPAGGSGPQTWWRRRRRSISRARQVELLLVADASMARLYGRGLQHYLLTLASIANRLYSHASIENHIRLAVVKVVVLGDKDKSLEVSKNAATTLKNFCKWQHQHNQLGDDHEEHYDAAILFTREDLCGHHSCDTLGMADVGTICSPERSCAVIEDDGLHAAFTVAHEIGHLLGLSHDDSKFCEETFGSTEDKRLMSSILTSIDASKPWSKCTSATITEFLDDGHGNCLLDLPRKQILGPEELPGQTYDATQQCNLTFGPEYSVCPGMDVCARLWCAVVRQGQMVCLTKKLPAVEGTPCGKGRICLQGKCVDKTKKKYYSTSSHGNWGSWGSWGQCSRSCGGGVQFAYRHCNNPAPRNNGRYCTGKRAIYRSCSLMPCPPNGKSFRHEQCEAKNGYQSDAKGVKTFVEWVPKYAGVLPADVCKLTCRAKGTGYYVVFSPKVTDGTECRLYSNSVCVRGKCVRTGCDGIIGSKLQYDKCGVCGGDNSSCTKIVGTFNKKSKGYTDVVRIPEGATHIKVRQFKAKDQTRFTAYLALKKKNGEYLINGKYMISTSETIIDINGTVMNYSGWSHRDDFLHGMGYSATKEILIVQILATDPTKPLDVRYSFFVPKKSTPKVNSVTSHGSNKVGSHTSQPQWVTGPWLACSRTCDTGWHTRTVQCQDGNRKLAKGCPLSQRPSAFKQCLLKKC
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Protease
>
Metallo protease
>
Metallo protease MAM clan
>
Metallo protease M12B subfamily
Function
Metalloproteinase that plays an important role in connective tissue organization, development, inflammation and cell migration. Extracellular matrix (ECM) degrading enzyme that show proteolytic activity toward the hyalectan group of chondroitin sulfate proteoglycans (CSPGs) including ACAN, VCAN, BCAN and NCAN (PubMed:16133547, PubMed:18992360). Cleavage within the hyalectans occurs at Glu-Xaa recognition motifs. Plays a role in embryonic development, including limb and cardiac morphogenesis, and skeletal muscle development through its VCAN remodeling properties. Cleaves VCAN in the pericellular matrix surrounding myoblasts, facilitating myoblast contact and fusion which is required for skeletal muscle development and regeneration (By similarity). Participates in development of brown adipose tissue and browning of white adipose tissue (By similarity). Plays an important role for T-lymphocyte migration from draining lymph nodes following viral infection.
    Show/Hide
Uniprot ID
Primary ID:
Q9UNA0

Secondarily ID:
Q52LV4
Q9UKP2
    Show/Hide
Ensembl ID
ENSG00000154736
HGNC ID
HGNC:221
Subcellular Location
Secreted
Extracellular space
Extracellular matrix
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000011 , CHO
Compound ID Compound Name Compound Formula
CP0052587
(2R,3R)-1-[4-(2-Chloro-4-fluoro-benzyloxy)-benzenesulfonyl]-3-hydroxy-3-methyl-piperidine-2-carboxylic acid hydroxyamide
   Show/Hide
C20H22ClFN2O6S
 1
1
IC50 = 6.3 nM
   TI
   LI
   LO
   TS
CP0191349
N-[[(2R)-1-[4-(but-3-enylamino)-6-[(2-thiophen-2-yl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-propylbenzenesulfonamide
   Show/Hide
C29H36N8O2S3
 1
1
IC50 = 30 nM
   TI
   LI
   LO
   TS
CP0191351
N-[[(2R)-1-[4-[(1-methylimidazol-4-yl)methylamino]-6-(propylamino)-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-propylbenzenesulfonamide
   Show/Hide
C25H37N9O2S
 1
1
IC50 = 30 nM
   TI
   LI
   LO
   TS
CP0191353
N-[[(2R)-1-[4-(but-3-enylamino)-6-[(2-thiophen-2-yl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]naphthalene-2-sulfonamide
   Show/Hide
C30H32N8O2S3
 1
1
IC50 = 40 nM
   TI
   LI
   LO
   TS
CP0191350
N-[[(2R)-1-[4-(but-3-enylamino)-6-[(2-thiophen-2-yl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-(trifluoromethyl)benzenesulfonamide
   Show/Hide
C27H29F3N8O2S3
 1
1
IC50 = 50 nM
   TI
   LI
   LO
   TS
CP0446326
N-[[(2R)-1-[4-[(2-phenyl-1,3-thiazol-4-yl)methylamino]-6-(propylamino)-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-propylbenzenesulfonamide
   Show/Hide
C30H38N8O2S2
 1
1
IC50 = 50 nM
   TI
   LI
   LO
   TS
CP0534190
N-[[(2R)-1-[4-(but-3-enylamino)-6-[(2-phenyl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-methoxybenzenesulfonamide
   Show/Hide
C29H34N8O3S2
 1
1
IC50 = 50 nM
   TI
   LI
   LO
   TS
CP0413961
N-[[(2R)-1-[4-(but-3-enylamino)-6-[(2-phenyl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-(trifluoromethyl)benzenesulfonamide
   Show/Hide
C29H31F3N8O2S2
 1
1
IC50 = 60 nM
   TI
   LI
   LO
   TS
CP0120704
N-[[(2R)-1-[4-(cyclopropylamino)-6-[(2-phenyl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-propylbenzenesulfonamide
   Show/Hide
C30H36N8O2S2
 1
1
IC50 = 70 nM
   TI
   LI
   LO
   TS
CP0110474
N-[[(2R)-1-[4-(2-cyanoethylamino)-6-[(2-phenyl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-propylbenzenesulfonamide
   Show/Hide
C30H35N9O2S2
 1
1
IC50 = 90 nM
   TI
   LI
   LO
   TS
CP0449949
N-[[(2R)-1-[4-(cyclopropylmethylamino)-6-[(2-thiophen-2-yl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-(trifluoromethyl)benzenesulfonamide
   Show/Hide
C27H29F3N8O2S3
 1
1
IC50 = 110 nM
   TI
   LI
   LO
   TS
CP0408592
N-[[(2R)-1-[4-(2-methylpropylamino)-6-[(2-phenyl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-propylbenzenesulfonamide
   Show/Hide
C31H40N8O2S2
 1
1
IC50 = 120 nM
   TI
   LI
   LO
   TS
CP0413962
N-[[(2R)-1-[4-(2-methoxyethylamino)-6-[(2-phenyl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-propylbenzenesulfonamide
   Show/Hide
C30H38N8O3S2
 1
1
IC50 = 210 nM
   TI
   LI
   LO
   TS
CP0523351
N-[[(2R)-1-[4-(but-3-enylamino)-6-[(2-phenyl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]benzenesulfonamide
   Show/Hide
C28H32N8O2S2
 1
1
IC50 = 230 nM
   TI
   LI
   LO
   TS
CP0534192
N-[[(2R)-1-[4-(butylamino)-6-[(2-thiophen-2-yl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-(trifluoromethyl)benzenesulfonamide
   Show/Hide
C27H31F3N8O2S3
 1
1
IC50 = 240 nM
   TI
   LI
   LO
   TS
CP0553415
N-[[(2R)-1-[4-(2-hydroxyethylamino)-6-[(2-phenyl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-propylbenzenesulfonamide
   Show/Hide
C29H36N8O3S2
 1
1
IC50 = 260 nM
   TI
   LI
   LO
   TS
CP0413963
N-[[(2R)-1-[4-(methylamino)-6-[(2-thiophen-2-yl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-(trifluoromethyl)benzenesulfonamide
   Show/Hide
C24H25F3N8O2S3
 1
1
IC50 = 390 nM
   TI
   LI
   LO
   TS
CP0534191
N-[[(2R)-1-[4-(butylamino)-6-[(6-methylpyridin-2-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-propylbenzenesulfonamide
   Show/Hide
C28H40N8O2S
 1
1
IC50 = 410 nM
   TI
   LI
   LO
   TS
CP0553414
N-[[(2R)-1-[4-(but-3-enylamino)-6-[(2-methyl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-(trifluoromethyl)benzenesulfonamide
   Show/Hide
C24H29F3N8O2S2
 1
1
IC50 = 430 nM
   TI
   LI
   LO
   TS
CP0523350
N-[[(2R)-1-[4-(butylamino)-6-[(2-thiophen-2-yl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-chlorobenzenesulfonamide
   Show/Hide
C26H31ClN8O2S3
 1
1
IC50 = 460 nM
   TI
   LI
   LO
   TS
CP0513291
N-[[(2R)-1-[4-(butylamino)-6-[(2-thiophen-2-yl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-3-chlorobenzenesulfonamide
   Show/Hide
C26H31ClN8O2S3
 1
1
IC50 = 700 nM
   TI
   LI
   LO
   TS
CP0553411
N-[[(2R)-1-[4-(butylamino)-6-[(2-thiophen-2-yl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-3,4-dimethylbenzenesulfonamide
   Show/Hide
C28H36N8O2S3
 1
1
IC50 = 720 nM
   TI
   LI
   LO
   TS
CP0553413
N-[[(2R)-1-[4-(benzylamino)-6-(but-3-enylamino)-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-(trifluoromethyl)benzenesulfonamide
   Show/Hide
C26H30F3N7O2S
 1
1
IC50 = 870 nM
   TI
   LI
   LO
   TS
CP0396384
N-[[(2R)-1-[4-(butylamino)-6-(thiophen-3-ylmethylamino)-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-propylbenzenesulfonamide
   Show/Hide
C26H37N7O2S2
 1
1
IC50 = 1170 nM
   TI
   LI
   LO
   TS
CP0413955
N-[[(2R)-1-[4-(butylamino)-6-[(2-thiophen-2-yl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-phenylbenzenesulfonamide
   Show/Hide
C32H36N8O2S3
 1
1
IC50 = 1250 nM
   TI
   LI
   LO
   TS
CP0446323
N-[[(2R)-1-[4-(butylamino)-6-[(2-thiophen-2-yl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-fluorobenzenesulfonamide
   Show/Hide
C26H31FN8O2S3
 1
1
IC50 = 1500 nM
   TI
   LI
   LO
   TS
CP0553412
N-[[(2S)-1-[4-(but-3-enylamino)-6-[(2-phenyl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-(trifluoromethyl)benzenesulfonamide
   Show/Hide
C29H31F3N8O2S2
 1
1
IC50 = 1560 nM
   TI
   LI
   LO
   TS
CP0413954
N-[[(2R)-1-[4-(butylamino)-6-[(2-thiophen-2-yl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-3-hydroxybenzenesulfonamide
   Show/Hide
C26H32N8O3S3
 1
1
IC50 = 1600 nM
   TI
   LI
   LO
   TS
CP0446325
N-[[(2R)-1-[4-(cyclopentylamino)-6-[(2-phenyl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-propylbenzenesulfonamide
   Show/Hide
C32H40N8O2S2
 1
1
IC50 = 1600 nM
   TI
   LI
   LO
   TS
CP0513290
N-[[(2R)-1-[4-(butylamino)-6-[(2-thiophen-2-yl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-cyanobenzenesulfonamide
   Show/Hide
C27H31N9O2S3
 1
1
IC50 = 1800 nM
   TI
   LI
   LO
   TS
CP0523355
N-[[(2R)-1-[4-(oxan-4-ylmethylamino)-6-[(2-phenyl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-propylbenzenesulfonamide
   Show/Hide
C33H42N8O3S2
 1
1
IC50 = 2140 nM
   TI
   LI
   LO
   TS
CP0408577
N-[[(2R)-1-[4-(butylamino)-6-[(2-thiophen-2-yl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-hydroxybenzenesulfonamide
   Show/Hide
C26H32N8O3S3
 1
1
IC50 = 2600 nM
   TI
   LI
   LO
   TS
CP0515629
N-[[(2R)-1-[4-[(2-thiophen-2-yl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-(trifluoromethyl)benzenesulfonamide
   Show/Hide
C23H22F3N7O2S3
 1
1
IC50 = 3500 nM
   TI
   LI
   LO
   TS
CP0523356
N-[[(2R)-1-[4-(2-cyclopropylethylamino)-6-[(2-phenyl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-propylbenzenesulfonamide
   Show/Hide
C32H40N8O2S2
 1
1
IC50 = 3800 nM
   TI
   LI
   LO
   TS
CP0396382
N-[[(2R)-1-[4-(butylamino)-6-[(2-thiophen-2-yl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-3-cyanobenzenesulfonamide
   Show/Hide
C27H31N9O2S3
 1
1
IC50 = 4100 nM
   TI
   LI
   LO
   TS
CP0413957
N-[[(2R)-1-[4-(butylamino)-6-[(4-cyanothiophen-2-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-propylbenzenesulfonamide
   Show/Hide
C27H36N8O2S2
 1
1
IC50 = 4100 nM
   TI
   LI
   LO
   TS
CP0513898
N-[[(2R)-1-[4-(butylamino)-6-[(2-thiophen-2-yl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-methylsulfonylbenzenesulfonamide
   Show/Hide
C27H34N8O4S4
 1
1
IC50 = 5300 nM
   TI
   LI
   LO
   TS
CP0523357
N-[[(2R)-1-[2-oxo-6-[(2-thiophen-2-yl-1,3-thiazol-4-yl)methylamino]-1H-1,3,5-triazin-4-yl]pyrrolidin-2-yl]methyl]-4-(trifluoromethyl)benzenesulfonamide
   Show/Hide
C23H22F3N7O3S3
 1
1
IC50 = 5300 nM
   TI
   LI
   LO
   TS
CP0452222
N-[[(2R)-1-[4-(butylamino)-6-(propan-2-ylamino)-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-propylbenzenesulfonamide
   Show/Hide
C24H39N7O2S
 1
1
IC50 = 5800 nM
   TI
   LI
   LO
   TS
CP0446324
N-[[(2R)-1-[4-(butylamino)-6-(cyclopropylmethylamino)-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-propylbenzenesulfonamide
   Show/Hide
C25H39N7O2S
 1
1
IC50 = 6500 nM
   TI
   LI
   LO
   TS
CP0413956
N-[[(2R)-1-[4-(butylamino)-6-(cyclopentylamino)-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-propylbenzenesulfonamide
   Show/Hide
C26H41N7O2S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0413959
N-[[(2R)-1-[4-(but-3-enylamino)-6-[(3-phenylphenyl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-(trifluoromethyl)benzenesulfonamide
   Show/Hide
C32H34F3N7O2S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0449935
N-[[(2R)-1-[4-(but-3-enylamino)-6-[(2-phenyl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-3-(trifluoromethyl)benzenesulfonamide
   Show/Hide
C29H31F3N8O2S2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0449936
N-[[(2R)-1-[4-(butylamino)-6-[(4-butylphenyl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-propylbenzenesulfonamide
   Show/Hide
C32H47N7O2S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0452223
N-[[(2R)-1-[4-(butylamino)-6-[(4-methylthiophen-2-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-propylbenzenesulfonamide
   Show/Hide
C27H39N7O2S2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0513292
N-[[(2R)-1-[4-(but-3-enylamino)-6-[(2-phenyl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-2-(trifluoromethyl)benzenesulfonamide
   Show/Hide
C29H31F3N8O2S2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0513293
3-fluoro-4-methyl-N-[(3R)-1-[4-(2-naphthalen-1-ylethylamino)-6-[[(3S)-2-oxoazepan-3-yl]amino]-1,3,5-triazin-2-yl]pyrrolidin-3-yl]benzenesulfonamide
   Show/Hide
C32H37FN8O3S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0513846
N-[[(2R)-1-[4-[methyl(propyl)amino]-6-[(2-phenyl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-propylbenzenesulfonamide
   Show/Hide
C31H40N8O2S2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0513901
N-[(3R)-1-[4-(benzylamino)-6-[[(3S)-2-oxoazepan-3-yl]amino]-1,3,5-triazin-2-yl]pyrrolidin-3-yl]-3-fluoro-4-methylbenzenesulfonamide
   Show/Hide
C27H33FN8O3S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0523352
N-[[(3R)-1-[4-(but-3-enylamino)-6-[(2-phenyl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-3-yl]methyl]-4-(trifluoromethyl)benzenesulfonamide
   Show/Hide
C29H31F3N8O2S2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0523353
N-[[(2R)-1-[4-(butylamino)-6-[(3-methylphenyl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-propylbenzenesulfonamide
   Show/Hide
C29H41N7O2S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0523354
N-[[(2R)-1-[4-(but-3-enylamino)-6-[(4-phenylphenyl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]-4-(trifluoromethyl)benzenesulfonamide
   Show/Hide
C32H34F3N7O2S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0545199
N-[[(2R)-1-[4-(but-3-enylamino)-6-[(2-phenyl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-2-yl]methyl]cyclopropanesulfonamide
   Show/Hide
C25H32N8O2S2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0545200
N-[[(3S)-1-[4-(but-3-enylamino)-6-[(2-phenyl-1,3-thiazol-4-yl)methylamino]-1,3,5-triazin-2-yl]pyrrolidin-3-yl]methyl]-4-(trifluoromethyl)benzenesulfonamide
   Show/Hide
C29H31F3N8O2S2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0052587
(2R,3R)-1-[4-(2-Chloro-4-fluoro-benzyloxy)-benzenesulfonyl]-3-hydroxy-3-methyl-piperidine-2-carboxylic acid hydroxyamide
   Show/Hide
C20H22ClFN2O6S
 2
1 IC50 = 1 nM
2 IC50 = 18 nM
CP0038344
(2S,3R)-2-(cyclopropylmethylamino)-N1-hydroxy-N4-((1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl)-3-(3-hydroxybenzyl)succinamide
   Show/Hide
C24H29N3O5
 1
1 IC50 = 12 nM
CP0132958
US9926281, Compound 255
   Show/Hide
C20H24F2N4O3
 1
1 IC50 = 19 nM
CP0234042
2-[[4-[(2-chloro-4-fluorophenyl)methoxy]phenyl]sulfonylamino]-N-hydroxyacetamide
   Show/Hide
C15H14ClFN2O5S
 1
1 Ki = 77 nM
CP0144469
N-hydroxy-2-[(4-phenoxyphenyl)sulfonylamino]acetamide
   Show/Hide
C14H14N2O5S
 1
1 Ki = 840 nM
CP0109082
N-hydroxy-2-[(4-phenylmethoxyphenyl)sulfonylamino]acetamide
   Show/Hide
C15H16N2O5S
 1
1 Ki = 21000 nM
Clinical Information about the Protein
Target 1 ( Aggrecanase (ADAMTS5) )
Target Type Clinical trial Target
Disease 1 Target-related Disease  1
1 Osteoarthritis [ICD-11: FA00-FA05]
Clinical Trial Drug(s) 1 Clinical Trial Drug  1
1 AGG-523 Phase 1
Osteoarthritis